Results

Pat Growth 25pctEbitda Margin CompressionEmphasis Of MatterRevenue Growth 20pctResults View source PDF

GANESHBE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.5%1-day move

₹98.70

prior close

₹99.80

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.1-3.0-1.8-4.3-5.5-4.8-4.1+3.3+13.6+11.1+8.3+4.2——

Up moveDown movePending

AI summary

Ganesh Benzoplast reported consolidated revenue of Rs. 4,114.19 million for FY26, up 9.9% from Rs. 3,743.11 million in FY25. Net profit after tax grew significantly to Rs. 733.36 million compared to Rs. 380.86 million in FY25, representing a 92.5% increase. However, EBITDA margin compressed from 32.1% to 27.2% year-on-year due to higher operating expenses. The auditors issued an unmodified opinion on both standalone and consolidated results. An emphasis of matter was raised regarding an FIR and EOW complaint against the company and its directors/KMPs related to alleged unauthorized loans and borrowings by a former director of GBL Chemical Ltd (WOS) in FY 2023-24; the company has filed a petition for quashing the FIR which is pending in Delhi High Court. The company also announced plans to form a foreign wholly-owned subsidiary in Singapore.

Likely market impact

Strong PAT growth of 92.5% driven partly by exceptional items reversal is positive, but EBITDA margin compression of ~5 percentage points signals rising cost pressures. The unresolved legal matter (FIR/EOW complaint) adds regulatory risk and warrants monitoring.